Nicole Vitullo, Director, 10% Owner at Esperion Therapeutics, Inc. (ESPR), bought 2,071,726 shares at $14.00 ($4.0M) on 2013-07-01, disclosed to the SEC on 2013-07-02.
Open-market purchase of $4.0M ESPR by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,786,012 | $0 | 0.0% |
| 2 | $14.00 | 4,791 | $67K | 1.7% |
| 3 | $14.00 | 280,923 | $3.9M | 98.3% |
| Total | $1.93 avg | 2,071,726 | $4.0M | 100% |
| Filing → |
| ESPR | SELL | 2018-01-26 | $1.7M | — | Filing → |
| ESPR | SELL | 2017-12-08 | $502K | — | Filing → |
| CLCD | SELL | 2016-05-02 | $2.1M | — | Filing → |